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Association of STAT4 rs7574865 with Sysceptibility to Juvenile Onset Systemic 
Lupus Erythematous in Pakistani Population 
(Perkaitan STAT4 rs7574865 dengan Kebolehlihatan terhadap Penyakit Lupus Erythematous Sistemik Juvenil pada 
Penduduk Pakistan)




Association of STAT4 (signal transducer and activator of transcription4) haplotype tagged by single nucleotide 
polymorphism (SNP) rs7574865 with systemic lupus erythematosus (SLE) was reported in different populations. This 
study was aimed to investigate a genetic association between STAT4 single nucleotide polymorphism (rs7574865) with 
susceptibility and clinical features of systemic lupus erythematosus in Pakistani population. A total of 75 clinically 
diagnosed individuals affected with SLE were enrolled from Children’s Hospital and Institute of Child Health Lahore. 
Sixty-eight healthy individuals of same ethnicity were also enrolled for this study. Clinical assessment of patients 
was done with the help of clinical features suggestive for SLE and some diagnostic tests specific for the disease were 
performed. SNP rs7574865 was genotyped by allele specific tetra ARMS PCR assay to check and compare the genotypic 
allele frequencies between SLE patients and healthy controls. Different statistical analysis ChiSquare, Fisher’s exact tests 
and binary Logistic Regression is performed to determine association of risk alleles with SLE in Pakistani population. 
p value less than >0.05 consider significant. This study showed the frequency of GG (28%), TT (12%), and GT alleles 
(60%) in SLE patients while controls showed allele frequencies of GG (5%), TT (29%) and GT (64%), respectively. The 
results showed that GG genotype and G allele in STAT4 rs7574865 was the risk allele for SLE while T allele proved to 
be the protective one for disease susceptibility when compared with healthy controls genotypic frequencies. This study 
suggests the strong association of SNP rs7574865 in STAT4 with the risk of SLE in Pakistani population. However, G 
allele showed no association with organ damage and immune disorder of SLE.
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ABSTRAK
Perkaitan antara STAT4 (transduser isyarat dan pengaktif transkripsi4) haplotip bertanda oleh polimorfisme 
nukleotida tunggal (SNP) rs7574865 dengan lupus eritematosus sistemik (SLE) dilaporkan dalam populasi berbeza. 
Kajian ini bertujuan untuk mengkaji hubungan genetik antara polimorfisme nukleotida tunggal STAT4 (rs7574865) 
dengan kerentanan dan ciri klinikal lupus eritematosus sistemik dalam populasi Pakistan. Seramai 75 individu yang 
didiagnosis secara klinikal terkesan oleh SLE telah didaftarkan dari Hospital Kanak-kanak dan Institut Kesihatan 
Kanak-kanak Lahore. Enam puluh lapan individu sihat daripada etnik yang sama juga telah didaftarkan untuk kajian 
ini. Penilaian klinikal pesakit dilakukan dengan bantuan ciri klinikal untuk SLE dan beberapa ujian diagnostik khusus 
untuk penyakit tersebut dijalankan. SNP rs7574865 digenotip dengan alel khusus tetra asai ARMS PCR untuk 
menyemak dan membandingkan frekuensi alel genotip antara pesakit SLE dan kawalan sihat. Analisis statistik 
ChiSquare berbeza, ujian tepat Fisher dan Regresi Logistik binari dijalankan untuk menentukan hubungan risiko alel 
dengan SLE dalam populasi Pakistan. Nilai p kurang daripada >0.05 dianggap signifikan. Kajian ini menunjukkan 
frekuensi alel GG (28%), TT (12%) dan GT (60%) pada pesakit SLE sementara kawalan menunjukkan frekuensi alel GG 
(5%), TT (29%) dan GT (64%). Hasil kajian menunjukkan bahawa genotip GG dan alel G pada STAT4 rs7574865 adalah 
alel risiko untuk SLE sementara alel T terbukti menjadi pelindung bagi kerentanan penyakit apabila dibandingkan 
dengan frekuensi genotipik kawalan sihat. Kajian ini mencadangkan perkaitan yang kuat oleh SNP rs7574865 dalam 
STAT4 dengan risiko SLE dalam populasi Pakistan. Walau bagaimanapun, alel G tidak menunjukkan kaitan dengan 
kerosakan organ dan gangguan imun SLE.
Kata kunci: Lupus eritematosus sistemik; polimorfisme nukleotida tunggal; STAT4
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INTRODUCTION
Systemic Lupus Erythematosus (SLE) is an autoimmune 
disease categorized by intolerance to body antigens and 
resulting in production of high amount of autoantibodies 
directed against DNA and other cellular components. 
Defective apoptosis of cells and their disturbed removal 
results in overall increase in target tissues and circulation 
and served as initiative base for autoimmune response 
(Piotr et al. 2012). Systemic Lupus Erythematosus (SLE) is a 
heterogenic inflammatory disorder. It is shown by various 
genetic, environmental, and pathogenic background 
that collectively evokes innate and adaptive immune 
responses with resultant immune complex deposition, 
overproduction of autoantibodies, inflammatory 
cytokine release, and disease onset (Su et al. 2012). Cell 
death pathway alterations are the potential source of 
auto antigens formation. Auto antigens released mainly 
from defective clearance of apoptotic cells presented by 
follicular dendritic cells to auto reactive B cells to generate 
autoantibodies that mimics the loss of self-tolerance 
an ultimate feature of SLE (Mahajan et al. 2016). SLE 
disease is immunologically characterized by presence of 
auto-immune complexes, antinuclear immunoglobulin 
and elevating level of complement proteins (Munoz et al. 
2005).  It is a multiorgan disorder in which autoimmune 
complexes causes severe harm especially to kidneys, skin, 
heart, joints, lungs, liver, and blood vessels (Cruz 2006). 
SLE immune responses act as disease activity markers. 
Eleven classification criteria have been established by 
the American College of Rheumatology any four of 
these clinical features confirms the classification as SLE 
(Kimberly et al. 2008). Moreover, SLE is manifested 
by various clinical features that include discoid rash, 
malar rash, arthritis, and photosensitivity, nephritis along 
with renal, neurologic, hematologic, immunologic, and 
mucocutaneous manifestations (Kuenkele et al. 2003). 
In a more recent review, the female-to-male ratio in the 
children was reported to be about 12:1.2. Age distribution 
for the disease ranged between 2 years and 80 years of age 
and in some cases older (Tsao & Grossman 2001). The 
global prevalence of SLE is approximately 20-70/100,000 
people (Habibi et al. 2011; Marti et al. 2008). Prevalence 
of SLE in the United States is reported to be 53 per 100,000 
while other estimations ranged from 322,000 to over 1 
million (Candace et al. 2013). In some population like 
Japan has lower prevalence rate of 3.2-19.3 (Kawasaki et 
al. 2008). However, the prevalence of SLE in Pakistan is 
still unknown. By recent studies and the number of genes 
identified so far, we would estimate that there are roughly 
20-50 of these, of which MHC (Harley et al. 2009), ITGAM 
(Hom et al. 2008), IRF5 (Gabriel et al. 2002), BLK, and 
STAT4 (Kimberly et al. 2008) provides overwhelming 
evidence for SLE, strong evidence described by PTPN22 
(Zervou et al. 2011) and FCGR2A (Kimberly et al. 2008) 
while good evidence evaluated by TNFSF4 as suggested by 
different studies. Various case control association studies 
have been done in United States (Kimberly et al. 2008), 
Japan (Taylor et al. 2008), Sweden (Morales et al. 2008), 
Mexico and North China (Han et al. 2009) who found 
the risk allele of STAT4 gene SNP rs7574865 associated 
with SLE.
STAT4 is a transcription factor (Munoz et al. 2005). 
It is required for the signal transduction of multiple 
cytokines including interleukin-12 (IL-12), IL-15, and 
IL-23 and therefore, is important in the differentiation of 
a Th1 cell immune response and has also been reported 
to be involved in the development of Th17 cells that are 
responsible for autoimmunity associated inflammation 
(Cruz 2006). STAT4 gene SNP rs7574865 polymorphism 
on chromosome 2q had shown strong risk for SLE (Abelson 
et al. 2009). This SNP along with other variants located in 
the third intron of the gene could influence transcription 
of gene by damaging a transcription factor binding (Zhao 
et al. 2009). A case control association study designed 
on Japanese population to test whether STAT1-STAT4 
region is associated with SLE and examined the potential 
genetic contribution of STAT4. They analysed 52 tag 
single nucleotide polymorphisms (SNPs) encompassing 
the STAT1-STAT4 region and also for associated SNPs and 
identified rs7574865, rs11889341, and rs10168266 in 
STAT4 showed most significant association. Subsequent 
association studies also confirmed a strong association 
of the subgroups of SLE with nephritis and anti-double-
stranded DNA antibodies (Kawasaki et al. 2008). A 
cohort reported on Swedish Caucasian SLE patients to 
elucidate the genetic components of lupus nephritis and 
identified association between the SNPs rs11889341, 
rs7574865, rs7568275, and rs7582694 of STAT4 gene 
and the development of lupus nephritis (Bolin et al. 2013). 
A study conducted on Coulombians aimed to identify that 
either TRAF1/C5 variants or STAT4 influence the risk 
of developing rheumatoid arthritis and systemic lupus 
erythematosus and their data strengthen the suggestion 
that STAT4 rs7574865 polymorphism is susceptibility 
factor for RA and SLE but TRAF1/C5 had no effect for 
the disease (Morales et al. 2008). A large SLE population 
is screened in Mexico by conducting a study on STAT4 
association with SLE through two independent effects 
that correlate with gene expression and act additively 
with IRF5 to increase the disease risk. They evaluated 
that out of four SNPs rs7574865, rs1467199, rs3821236 
and rs7574865, three SNPs rs3821236, rs3024866 and 
rs7574865 remained significant throughout the study 
(Abelson et al. 2009). In Chinese Northern Han population, 
STAT4 association with systemic lupus erythematosus 
was investigated and showed TT genotype and T allele in 
STAT4 rs7574869 were the susceptibility factors for SLE, 
especially for male SLE patients (Yin et al. 2010). 
In the present study, we investigated the association 




This case control study conducted after taking approval 
from Institutional review board (IRB) of Department of 
Biotechnology, Lahore College for Women University, 
Lahore, Pakistan.  Blood samples (3-5 mL) were taken from 
SLE patients recruited from Medical general ward (M-1) 
and Nephrology ward of Children’s Hospital & Institute of 
Child Health Sciences, Lahore from September 2017 to 
September 2018. Written informed consent was obtained 
from parents on behalf of their young children. All basic 
parameters including duration of disease, age at disease, 
onset, and clinical features of disease were recorded. 
An inclusion criterion was clinical presentation of SLE 
including skin rash, photosensitivity, oral ulcer, arthritis, 
nephritis, serositis, and neuropsychiatric features of the 
patients. Blood samples of sixty five normal healthy 
controls of same ethnic groups with no familial history 
of SLE or any other autoimmune disease were collected 
for this study.   
Total Genomic DNA of 75 affected and 65 healthy 
controls was extracted from peripheral blood leukocytes 
using a simple non organic blood extraction method that 
involves cell lysis, proteinase K digestion followed by used 
of salt extraction for the precipitation of contaminating 
proteins (Grimberg et al. 1989). Approximately 2ng of 
the genomic DNA was used to genotype each sample. 
Genotyping of STAT4 SNP rs7574865 was performed 
by Tetra ARMS PCR according to the manufacturer’s 
protocols. PCR amplification was done using 2 sets 
of primers. The outer primer set included forward 
outer: 5’-ATCCACAAATTATATCTTTTCCATTTTTT-3’ 
( 4 1 0 b p )  a n d  r e v e r s e  o u t e r : 
5’-GGAATTTTTGTTATGATGAAAATAGCTT-3’ (410bp) 
while the inner primer sets comprised forward inner 
T allele: -AGTATGAAAAGTTGGTGACCAAAATATT- 
( 1 8 0 b p )  a n d  r e v e r s e  i n n e r  G  a l l e l e : 
-AATTCCACTGAAATAAGATAACCACTACTC- (288bp). 
(http://primer1.soton.ac.uk/primer1.html.)  12 µL of PCR 
reaction was transferred to a 2% agarose gel and samples 
were electrophoresed at 110 volts for 30 min. Bands were 
finally visualized by UV transilluminator. The amplified 
DNA bands of the specific STAT4 SNP rs7574865 primer 
showed common forward outer band of 410bp while G 
allelic band comprised of 288bp and T allelic band of 
288bp (Figure 1).
STATISTICAL ANALYSIS
Statistical analysis was performed using SPSS 17.0 
software (Armonk, US). The association between the 
genotype in patients compared to controls is analyzed 
by computing the Pearson chi-square (χ2) and Fisher’s 
exact test. Binary Logistic Regression is also performed 
to determine odds ratio for estimating relative measure 
of risk alleles with SLE in Pakistani population. In all 
statistical analyses, a ‘p’ value of less than 0.05 (95% QI) 
was considered to be statistically significant. 
RESULTS
In this study, among 75 patients, 15 patients were male 
and 80 were female patients. Age of SLE patients ranged 
from 5-16 years with average of 11.0±2.34. Average age of 
male SLE patients was 11±2.34 years while females were 
diagnosed at an average age of 11.2±2.25. Major incidence 
of SLE was observed in age group of 11-13 years, as 46% 
patients belonged to this group. Trends of incidence for 
SLE in different age groups are shown in Table 1. 
SNP rs7574865 was genotyped in 75 SLE patients and 
68 healthy controls genomic DNA samples. The rs7574865 
G allele (28%) in the patients was significantly higher than 
the control group (5%). The rs7574865 TT homozygous 
genotype frequency was lower in patients than controls 
and counted as 12% and 29%, respectively. GG genotype 
of the STAT4 rs7574865 was significantly associated 
with an increased risk of SLE when TT was taken as a 
reference considering the control group (Figure 2). By 
the regression analysis on this data, it is concluded that 
GG allele is related with increased risk of disease (OR= 
7.807) and this risk is statistically significant (p-value = 
0.020) (Table 3), while TT allele is a protective genotype 
for SLE patients in Pakistan. It was investigated whether 
risk GG genotype of STAT4 rs7574865 was correlated with 
specific clinical manifestations of SLE and found no 
significant correlation between frequencies of G allele in 
STAT4 rs7574865 and specific clinical features associated 





FIGURE 1. Some of the amplified PCR products of SLE cases resolved on 2% agarose gel for 









FIGURE 1. Some of the amplified PCR products of SLE cases resolved on 2% 
agarose gel for SNP rs7574865. L represent the Gene ruler ladder
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TABLE 1. Age stratification in patients with SLE













5-7 1 4 5 6.6%
8-10 5 17 22 29.3%
11-13 5 30 35 46%
14-16 3 7 10 %






GT (%) GG (%) TT (%)
1. Malar rash 69 (92%) 45 (65%) 9 (13%) 15 (21%)
2. Discoid rash 54 (72%) 36 (66%) 6 (11%) 15 (27%)
3. Photosensitivity 30 (40%) 18 (60%) 3 (10%) 9 (30%)
4. Oral ulcers 48 (64%) 27(56%) 9 (12%) 15 (31%)
5. Arthritis 69 (92%) 39(56%) 9 (13%) 21 (30%)
6. Neurological disorder 21 (28%) 15 (71%) 3 (14%) 3 (14%)
7. Nephritis 57 (76%) 33 (57%) 9 (15%) 15 (26%)
8. Serositis 42 (56%) 30 (71%) 6 (14%) 6 (14%)





























FIGURE 2. Pie charts showing genotypic frequencies in SLE patients and controls for STAT4 
SNP (rs7574865) 
 
FIGURE 2. Pie charts showing genotypic frequencies in SLE patients and 
controls for STAT4 SNP (rs7574865)
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TABLE 3. Association between alleles and SNP rs7574865 of STAT4gene







AlleleGG 2.055 .886 5.378 1 .020* 7.807 1.375 44.340
AlleleGT -.065 .850 .006 1 .939* .937 .177 4.962
AlleleTT -1.131 .873 1.676 1 .195* .323 .058 1.788
Constant .092 .826 .012 1 .911* 1.096
a. Variable(s) entered on step 1: Allele GG, Allele GT, Allele TT
*Logistic regression analysis values
  Bold: statistically significant 
DISCUSSION
During the past few decades’ genome association studies 
identified various genes associated with SLE confirmed 
among different populations (Harley et al. 2009). Prevalence 
of SLE was most commonly reported in Hispanics, African, 
and American populations (Hoffecker et al. 2013). In our 
study, seventy-five patients enrolled with age ranges from 
5 to 16 years as this study included patients of younger 
age and early adulthood with an average of 11.0±2.34. 
Female to male ratio is 4:1 and more female between 11 
and 13 years were identified affected with SLE as this 
is the age of endogenous sex hormones production that 
strongly predisposes to autoimmune diseases (Munoz et 
al. 2005). Our data is justified by several studies conducted 
in India (Malaviya et al. 1997), Saudia Arabia (AlArfaj 
& Khalil 2009), Iran (Mirkazemi et al. 2013) and Oman 
(Al-Maini et al. 2003). However, no study was found 
that included SLE patients with age ranging between 
5 and 16 years. STAT4 SNP rs7574865 located in third 
intron of the gene was strongly associated with SLE in the 
various populations (Candace et al. 2013; Kawasaki et 
al. 2008; Morales et al. 2008; Taylor et al. 2008; Zhao et 
al. 2009). In the present study, SNP rs7574865 of STAT4 
was significantly associated with predisposition to SLE 
in Pakistani population. Frequency of homozygous GG 
genotype is increased in patients affected with SLE (28%) 
as compared to healthy control (5%) and frequency of 
homozygous TT genotype is declined to (12%) in SLE 
patient while increased percentage of TT genotype is 
shown in controls (29%). These present finding were 
consistent to conclude that G allele of GG genotype was 
referred to as risk allele and in accordance T allele of TT 
genotype was referred to as the protective one. However, 
heterozygous GT genotypes seem no consistency with 
any protective or risk phenomena for healthy controls 
(64%) and SLE patient (60%) and make no interpretable 
findings about disease. These results were not consistent 
with the reports from Iranian (Mirkazemi et al. 2013), 
Northern Chinese (Yin et al. 2010), Coulombians (Abelson 
et al. 2009) and Japanese studies (Hom et al. 2008) which 
reported that TT genotype of STAT4 SNP rs7574865 as risk 
factor for predisposition to SLE. Reasonable differences 
between our results and previous studies were may be due 
to different race and ethnic groups. They might be due to 
different sample sizes in multiple studies.
Severity of clinical manifestation in SLE varies with 
age, sex, race, and geographical distribution (Marti et al. 
2008). The present study proposed that minor G allele 
of STAT4 SNP rs7574865 does not correlated with SLE 
specific clinical features. Previous studies conducted 
in USA (Candace et al. 2013), Europe and Sweden 
(Siggurdson et al. 2008) showed stronger association of 
SLE with nephritis and anti dsDNA antibody production. 
All the mentioned findings done in different populations 
were contradictory to our study and possible explanations 
for these findings were might be genetic heterogeneity, 
variability of clinical features specified for SLE and 
patient interaction with different environmental factors 
that varies among different populations. However, a case 
control study conducted in Iran also showed that risk T 
allele in their population does not correlates with clinical 
manifestations suggestive of SLE (Mirkazemi et al. 2013). 
In China, results data augmented that risk T allele does 
not show any association with SLE related heamatological 
and clinical investigations (Yin et al. 2010). The results of 
these studies are correlated with this study. 
CONCLUSION
It is concluded from this study that there is strong 
association of SNP rs7574865 in STAT4 Gene with the 
risk of SLE in Pakistani population. The GG genotype 
or G allele in rs7574865 was found in correlation with 
risk of SLE. However, the G allele in rs7574865 showed 
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